Division of Research Policies & Procedures
- 10.1.1 Research Misconduct Policy
- 10.1.2 Financial Conflict of Interest (FCOI) Policy
- 10.1.3 Faculty-level Research Appointments
- 10.1.4 Sponsored Research Incentive Policy
- 10.1.5 Faculty-Level Clinical Research Appointments
- 10.1.6 Research Data Policy
- 10.1.7 Authorship and Publication of Scholarly Work
10.2 Sponsored Programs Policies
- 10.2.1 Account Set-up for Projects involving Human Subjects, Animal Subjects, and/or Biohazardous Materials UPDATED 6/2024
- 10.2.2 Budget Amendments Policy for Federal and Non-Federal Sponsored Programs
- 10.2.5 Facilities and Administrative Costs on Sponsored Programs UPDATED 3/2023
- 10.2.6 Funding in Anticipation of Award Policy UPDATED 2/2025
- 10.2.8 Principal Investigator Eligibility Policy UPDATED 12/2025
- 10.2.10 Proposal Submission Deadlines Policy
- 10.2.11 Pre-Proposal Submission Policy
- 10.5.16 Subaward and Monitoring Policy UPDATED 7/2025
10.3 Research Integrity / Institutional Review Board
- 10.3.1 Human Research Protections Program- Governing Principles, Policy and Organizational Structure
- 10.3.2 Human Subjects Research (HSR) Determinations
- 10.3.3 Human Subjects Research Protection Training
- 10.3.4 International Research
- 10.3.5 Reportable Events (Serious Adverse Events, Unanticipated Problems, and Non-Compliance)
- 10.3.6 Research with Vulnerable Populations
- 10.3.7 Disclosure and Use of Protected Health Information (PHI) in Research
- 10.3.8 Students as Research Subjects
- 10.3.9 Closing an IRB Approved Study
- 10.3.12 FDA Regulated Products in Human Subject Research
- 10.3.14 Continuing Review of IRB Approved Studies
- 10.3.18 Institutional Authorization Agreements (IAA) and Reliance Agreements
10.4 Research Integrity/Institutional Animal Care and Use Committee
- 10.4.1a The Florida Atlantic Animal Care and Use Program: Organizational Structure (UPDATED DECEMBER 2024)
- 10.4.1b Institutional Animal Care and Use Committee: Role and Function (UPDATED NOVEMBER 2023)
- 10.4.1c Protocol and Amendment Review (UPDATED OCTOBER 2024)
- 10.4.2 Exempt Animal Studies (UPDATED AUGUST 2024)
- 10.4.3 Animal Procurement and Acclimation (UPDATED JANUARY 2024)
- 10.4.4 Satellite Animal Housing Facilities (UPDATED AUGUST 2023)
- 10.4.5 Recordkeeping Requirements for Research Personnel (UPDATED DECEMBER 2024)
- 10.4.6 Anesthesia, Surgeries and Analgesia (UPDATED MARCH 2026)
- 10.4.7 Sanitization of Housing and Experimental Equipment by Research Laboratories and Comparative Medicine (UPDATED AUGUST 2023)
- 10.4.8 Identification of Rodents (UPDATED SEPTEMBER 2025)
- 10.4.9 Animal Research Involving Hazardous Materials (UPDATED SEPTEMBER 2024)
- 10.4.10 Animal Transport (UPDATED APRIL 2025)
- 10.4.11 Euthanasia Methods (UPDATED AUGUST 2023)
- 10.4.12 Diet and Fluid Modification in Rodents (UPDATED MAY 2023)
- 10.4.13 Recognition and Alleviation of Pain and Distress in Research Animals (UPDATED NOVEMBER 2023)
- 10.4.14 Physical Restraint of Captive Animals (UPDATED DECEMBER 2025)
- 10.4.15 Number Tracking and Disposition of Animals including Transfer, Reuse, Death and Reporting of Adverse Events (UPDATED JUNE 2023)
- 10.4.16 Access Control and General Requirements for Working in Animal Facilities (UPDATED FEBRUARY 2025)
- 10.4.17 Social Housing and Environmental Enrichment (UPDATED AUGUST 2023)
- 10.4.18 Controlled Substances (UPDATED January 2025)
- 10.4.19 Expired and Suspended Protocols (UPDATED DECEMBER 2025)
- 10.4.20 Rodent Breeding Colony Management (NEW)
- 10.4.21 Medical Surveillance Program for Animal Users (UPDATED AUGUST 2024)
- 10.4.22 Personnel Training in the Care and Use of Animals (UPDATED APRIL 2026)
- 10.4.23 Tumor Burden in Rodents (UPDATED DECEMBER 2024)
- 10.4.24 Use of Fish (UPDATED AUGUST 2023)
- 10.4.25 Use of Non-Pharmaceutical Grade Substances in Laboratory Animals (UPDATED OCTOBER 2025)
- 10.4.26 Wildlife Research Policy (UPDATED JUNE 2023)
- 10.4.27 Photography and Videography in Research Animals (UPDATED MAY 2023)
- 10.4.28 Post Approval Monitoring (PAM) Program (NEW)
10.5 Research Accounting
- 10.5.1 Accounting for Payments to Research Study Subjects, Including Gift Cards
- 10.5.2 Accounts Receivable Collection Policy
- 10.5.3 Award Close Out
- 10.5.4 Cost Share Policies and Procedures
- 10.5.5 Cost Transfer Policy (UPDATED as of 8/12/2020)
- 10.5.6 Deliverable Invoice
- 10.5.7 Direct Costs
- 10.5.8 Equipment Policy for Federal Sponsored Programs
- 10.5.10 Financial Reporting
- 10.5.11 Institutional Base Salary
- 10.5.13 Program Income
- 10.5.16 Subaward and Monitoring Policy
- 10.5.17 Time and Effort Certification
- 10.5.18 Unreimbursed Costs on Contracts and Grants
- 10.5.19 Invoice Policy
10.7 Florida Atlantic Institutes and Centers
10.8 Florida Atlantic Core Facilities
10.10 Florida Atlantic Export Control
10.11 Florida Atlantic Postdoctoral Affairs
10.12 Research Integrity/Institutional Biosafety Committee
- 10.12.01 Florida Atlantic Biosafety Program Organizational Structure (UPDATED NOVEMBER 2024)
- 10.12.02 Institutional Biosafety Committee Functions (UPDATED NOVEMBER 2024)
- 10.12.03 Biosafety Review Process (UPDATED SEPTEMBER 2023)
- 10.12.04 Training (UPDATED JULY 2023)
- 10.12.05 Noncompliance (UPDATED SEPTEMBER 2023)
- 10.12.06 Reporting
Division of Research Guidance Documents/Links
- Request for Exemption to Conduct Business With FAU
- Intellectual Property Disclosure Process
- Technology Transfer Process
- Export Control
- Florida Atlantic Policies and Procedures
- Limited Submissions Internal Applications
- Code of Federal Regulations
- NIH Grants Policy and Guidelines
- NSF Grant Policy Manual
- OMB Uniform Guidance
- OSHA Regulations
- DS2
- Florida Statutes